DOI: http://dx.doi.org/10.18203/2349-2902.isj20193368

A curious case of chest wall lump turning out to be isolated primary cutaneous aspergillosis in an immunocompetent female: a case report

Manmohan Madhukar Kamat, Neeraj Pratap Singh, Kartik Nattey, Shravani Shetye, Seema Barman

Abstract


Aspergillosis is a fungal infection caused by certain types of mold. Although they are found commonly throughout nature, these molds normally don’t cause problems. Aspergillosis is an uncommon fungal infection in which primary cutaneous sites are very rare. Most cases occur in immunodepressed patients and are disseminated in the blood. We report a 32 year old female with primary cutaneous aspergillosis in an otherwise immunocompetent female with no other systemic manifestation. 32 year old female presenting with left lower chest lump fixated to chest wall. It was thought of as neoplasm clinically and radiologically mostly soft tissue neoplasm and was planned for wide excision of lump with segmental excision of involved rib segment. On histopathological examination of the specimen, it showed aspergillus organisms. It is a case of primary cutaneous manifestation of aspergillosis as fixed chest wall lump with otherwise no Broncho-pulmonary or systemic involvement in an immunocompetent patient. Primary cutaneous aspergillosis presenting as isolated chest wall lump without any Broncho pulmonary or systemic involvement in an otherwise immunocompetent individual is an extremely rare manifestation.


Keywords


Invasive aspergillosis, Aspergilloma, Cutaneous aspergillosis

Full Text:

PDF

References


Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, et al. Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review. Medicine Baltimore. 2015;94(26):e1018.

Tahir C, Garbati M, Nggada HA, Yawe EHT, Abubakar AM. Primary Cutaneous Aspergillosis in an Immunocompetent Patient, J Surg Tech Case Rep. 2011;3(2):94–6.

van Burik JH, Colven R, Spach DH. Cutaneous Aspergillosis. J Clin Microbiol. 1998;36(11):3115–21.

Xiaoyan L, Jun Y, Weiyuan M. Primary cutaneous aspergillosis caused by Aspergillus.fumigatus in an immunocompetent patient: A case report, Medicine: 2017;96(48):e8916.

van Burik JA, Colven R, Spach DH. Cutaneous aspergillosis. J Clin Microbiol. 1998;36:3115–21.

Tatara AM, Mikos AG, Kontoyiannis DP. Factors affecting patient outcome in primary cutaneous aspergillosis. Medicine (Baltimore). 2016;95:e3747.

Lat A, Thompson GR. Update on the optimal use of voriconazole for invasive fungal infections, Infect Drug Resist. 2011;4:43–53.

Paterson DL. New clinical presentations of invasive Aspergillosis in non-conventional hosts. Eur J Clin Microbiol Infect Dis. 2004;10:24–30.

Benedict LM, Kusne S, Torre-Cisneros J, Hunt SJ. Primary cutaneous fungal infection after Solid organ transplantation: Report of five cases and review. Clin Infect Dis. 1992;15:17–21.

Loria KM, Salinger MH, Frohlich TG, Gendelman Cook FV, Arentzen CE. Primary cutaneous aspergillosis in a heart transplant recipient treated with surgical excision and oral itraconazole. J Heart Lung Transplant. 1992;11:156–9.